- Home
- TIL vs UONEK Comparison
TIL vs UONEK Comparison
Compare TIL & UONEK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TIL
- UONEK
- Stock Information
- Founded
- TIL 2018
- UONEK 1980
- Country
- TIL United States
- UONEK United States
- Employees
- TIL N/A
- UONEK N/A
- Industry
- TIL Biotechnology: Pharmaceutical Preparations
- UONEK Broadcasting
- Sector
- TIL Health Care
- UONEK Consumer Discretionary
- Exchange
- TIL Nasdaq
- UONEK Nasdaq
- Market Cap
- TIL 218.4M
- UONEK 63.4M
- IPO Year
- TIL 2021
- UONEK N/A
- Fundamental
- Price
- TIL $34.51
- UONEK $1.14
- Analyst Decision
- TIL Buy
- UONEK
- Analyst Count
- TIL 3
- UONEK 0
- Target Price
- TIL $103.67
- UONEK N/A
- AVG Volume (30 Days)
- TIL 170.6K
- UONEK 19.1K
- Earning Date
- TIL 11-11-2024
- UONEK 11-07-2024
- Dividend Yield
- TIL N/A
- UONEK N/A
- EPS Growth
- TIL N/A
- UONEK N/A
- EPS
- TIL N/A
- UONEK N/A
- Revenue
- TIL N/A
- UONEK $460,323,000.00
- Revenue This Year
- TIL N/A
- UONEK N/A
- Revenue Next Year
- TIL N/A
- UONEK N/A
- P/E Ratio
- TIL N/A
- UONEK N/A
- Revenue Growth
- TIL N/A
- UONEK N/A
- 52 Week Low
- TIL $6.08
- UONEK $0.97
- 52 Week High
- TIL $92.00
- UONEK $5.92
- Technical
- Relative Strength Index (RSI)
- TIL 42.71
- UONEK 55.85
- Support Level
- TIL $29.95
- UONEK $1.03
- Resistance Level
- TIL $44.50
- UONEK $1.15
- Average True Range (ATR)
- TIL 3.96
- UONEK 0.04
- MACD
- TIL -0.87
- UONEK 0.02
- Stochastic Oscillator
- TIL 29.27
- UONEK 86.11
About TIL Instil Bio Inc.
Instil Bio Inc is a clinical-stage biopharmaceutical company focused on developing a cell therapy pipeline of autologous tumor infiltrating lymphocyte, or TIL, therapies for the treatment of patients with cancer. It is also engaged in developing a novel class of genetically engineered TIL therapies using its Co-Stimulatory Antigen Receptor, or CoStAR, platform. Its pipeline includes ITIL-306 which expresses a CoStAR molecule designed to recognize FRα, a tumor-associated antigen that is expressed on numerous solid tumors, including ovarian cancer, uterine cancer, NSCLC, and renal cancer.
About UONEK Urban One Inc. Class D
Urban One Inc is an urban oriented, multi-media company. Its business is radio broadcasting franchise that is the radio broadcasting operation that targets African-American and urban listeners. It operates through the following segments: Radio Broadcasting, Reach Media, Digital, and Cable Television. The Radio Broadcasting segment includes all the broadcasting related operations. The Reach Media segment consists of the Tom Joyner Morning Show and its related activities. The Digital segment focuses on its online business, including the operations of Interactive One. The Cable Television segment deals with TV One's operations.